Tokyo, Japan

Chiyoka Ozaki

This inventor holds 6 USPTO granted patents. Top assignee: Kowa Company Limited. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiyoka Ozaki. Retrieved from https://idiyas.com/inventor/chiyoka-ozaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Chiyoka Ozaki: Innovator in Amide Compounds

Introduction

Chiyoka Ozaki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 6 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Ozaki's latest patents focus on amide compounds and medications containing these compounds. One of her notable inventions provides a novel compound that exhibits ACAT inhibiting activity. This innovation is represented by specific chemical formulas, showcasing her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Chiyoka Ozaki has been associated with Kowa Company Limited, where she has played a vital role in research and development. Her work has contributed to advancements in therapeutic options for various medical conditions.

Collaborations

Ozaki has collaborated with esteemed colleagues, including Yukihiro Sato and Mitsuteru Hirata. These partnerships have enhanced her research efforts and expanded the impact of her inventions.

Conclusion

Chiyoka Ozaki's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work continues to influence the development of new medications and compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…